Stephen Robinson serves as the National Market Access Lead for Immunology in the UK and Ireland at UCB since August 2023. Prior to this role, Stephen was the Health Economics & Outcomes Research Lead at LEO Pharma UK/IE from May 2021 to August 2023, where responsibilities included leading cross-functional development and submissions of high-quality HTA evidence dossiers for market access. Stephen's previous experience at the National Institute for Health and Care Excellence (NICE) from January 2016 to May 2021 involved providing technical guidance on clinical trial programs and health economic evaluations, as well as leading HTA submissions across various therapeutic areas. Stephen's early career included analytical roles at NICE that supported NHS England and the development of evidence-based clinical guidelines. Stephen holds a PGCert in Public Health from The University of Manchester and a BSc in Biology (Biomedical Sciences) from Nottingham Trent University.
This person is not in any teams
This person is not in any offices